E
BioHarvest Sciences Inc. BHSC
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 5/11/2023Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to E+ from D- on 5/11/2023 due to a decline in the solvency index, growth index and total return index. The quick ratio declined from 0.34 to 0.26, debt to equity increased from -1.72 to -1.5, and operating cash flow declined 0.24% from -$2.5M to -$2.5M.
D
Sell 3/14/2023Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell 2/23/2023Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell 2/8/2023Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index.
D
Sell 11/29/2022Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to D from D+ on 11/29/2022 due to a decline in the solvency index. Debt to equity increased from -2.99 to -1.72, and the quick ratio declined from 0.4 to 0.34.
D
Sell 8/30/2022Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D+ from D on 8/30/2022 due to an increase in the valuation index, growth index and total return index. Operating cash flow increased 30.64% from -$2.5M to -$1.74M, total revenue increased 19.89% from $699 to $838, and EBIT increased 6.38% from -$2.63M to -$2.47M.
D
Sell 4/29/2022Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D from D- on 4/29/2022 due to a large increase in the growth index, solvency index and volatility index. EBIT increased 55.87% from -$2.68M to -$1.18M, earnings per share increased from -$0.007 to -$0.0039, and total revenue increased 13.35% from $644 to $730.
D
Sell 4/20/2022Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and growth index. Earnings per share declined from $0.0042 to -$0.007, and EBIT declined 12.17% from -$2.39M to -$2.68M.
D
Sell 11/23/2021Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell 11/8/2021Downgrade
BioHarvest Sciences Inc. (BHSC) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index.
D
Sell 5/3/2021Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D from D- on 5/3/2021 due to an increase in the total return index, growth index and volatility index. Total revenue increased 394.34% from $53 to $262, and operating cash flow increased 33.12% from -$1.86M to -$1.25M.
D
Sell 1/4/2021Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to D- from E+ on 1/4/2021 due to a noticeable increase in the growth index, solvency index and total return index. Debt to equity declined from -0.01 to -0.03, the quick ratio increased from 1.01 to 2.42, and total revenue increased 35.9% from $39 to $53.
E
Sell 10/1/2020Upgraded
BioHarvest Sciences Inc. (BHSC) was upgraded to E+ from E on 10/01/2020.
E
Sell 8/28/2020None
BioHarvest Sciences Inc. (BHSC) was downgraded to E from U on 08/28/2020.
Weiss Ratings